Boala Alzheimer (Romanian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Boala Alzheimer" in Romanian language version.
refsWebsite
Global rank
Romanian rank
1st place
1st place
3,258th place
1,726th place
5th place
11th place
43rd place
2nd place
2,299th place
89th place
7th place
25th place
719th place
901st place
8,771st place
low place
low place
low place
low place
50th place
low place
98th place
biogen.com
investors.biogen.com
descopera.ro
- Dementa – cea mai costisitoare boala a secolului, 21 septembrie 2010, Descoperă, accesat la 23 mai 2012
doi.org
- Burns A, Iliffe S (februarie 2009). „Alzheimer's disease”. BMJ. 338: b158. doi:10.1136/bmj.b158. ISSN 0959-8138. PMID 19196745.
- Querfurth HW, LaFerla FM (ianuarie 2010). „Alzheimer's disease”. The New England Journal of Medicine. 362 (4): 329–44. doi:10.1056/NEJMra0909142. PMID 20107219.
- Todd S, Barr S, Roberts M, Passmore AP (noiembrie 2013). „Survival in dementia and predictors of mortality: a review”. International Journal of Geriatric Psychiatry. 28 (11): 1109–24. doi:10.1002/gps.3946. PMID 23526458.
- Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (martie 2011). „Alzheimer's disease”. Lancet. 377 (9770): 1019–31. doi:10.1016/S0140-6736(10)61349-9. PMID 21371747.
-
Hsu D, Marshall GA (). „Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward”. Current Alzheimer Research. 14 (4): 426–40. doi:10.2174/1567205013666160930112125. PMC 5329133
. PMID 27697063. - Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (iulie 2007). „Systematic review of information and support interventions for caregivers of people with dementia”. BMC Geriatrics. 7: 18. doi:10.1186/1471-2318-7-18. PMC 1951962 . PMID 17662119.
- Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (aprilie 2015). „Exercise programs for people with dementia”. The Cochrane Database of Systematic Reviews (Submitted manuscript). 132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMID 25874613.
- GBD 2015 Disease Injury Incidence Prevalence Collaborators (octombrie 2016). „Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 . PMID 27733282.
- Mendez MF (noiembrie 2012). „Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD”. Archives of Medical Research. 43 (8): 677–85. doi:10.1016/j.arcmed.2012.11.009. PMC 3532551 . PMID 23178565.
- GBD 2015 Mortality Causes of Death Collaborators (octombrie 2016). „Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903 . PMID 27733281.
- Berchtold NC, Cotman CW (). „Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s”. Neurobiology of Aging. 19 (3): 173–89. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992.
- Bonin-Guillaume S, Zekry D, Giacobini E, Gold G, Michel JP (ianuarie 2005). „[The economical impact of dementia]”. Presse Médicale (în French). 34 (1): 35–41. doi:10.1016/s0755-4982(05)83882-5. PMID 15685097.
- Meek PD, McKeithan K, Schumock GT (). „Economic considerations in Alzheimer's disease”. Pharmacotherapy. 18 (2 Pt 2): 68–73; discussion 79–82. doi:10.1002/j.1875-9114.1998.tb03880.x (inactiv ). PMID 9543467. Arhivat din original la . Accesat în .
- Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B (ianuarie 2007). „Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline”. European Journal of Neurology. 14 (1): e1–26. doi:10.1111/j.1468-1331.2006.01605.x. PMID 17222085.
- Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (septembrie 2004). „Multiple cognitive deficits during the transition to Alzheimer's disease”. Journal of Internal Medicine. 256 (3): 195–204. doi:10.1111/j.1365-2796.2004.01386.x. PMID 15324363.
- Nygård L (). „Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?”. Acta Neurologica Scandinavica. Supplementum. 179 (s179): 42–6. doi:10.1034/j.1600-0404.107.s179.8.x. PMID 12603250.
- Arnáiz E, Almkvist O (). „Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease”. Acta Neurologica Scandinavica. Supplementum. 179: 34–41. doi:10.1034/j.1600-0404.107.s179.7.x. PMID 12603249.
- Landes AM, Sperry SD, Strauss ME, Geldmacher DS (decembrie 2001). „Apathy in Alzheimer's disease”. Journal of the American Geriatrics Society. 49 (12): 1700–7. doi:10.1046/j.1532-5415.2001.49282.x. PMID 11844006.
- Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. (ianuarie 2004). „Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials”. Archives of Neurology. 61 (1): 59–66. doi:10.1001/archneur.61.1.59. PMID 14732621.
evz.ro
- Peste 200.000 de români cu demență, lăsați în voia sorții de Guvern, 28 februarie 2014, Evenimentul zilei, accesat la 28 februarie 2014
fda.gov
- „Information for Healthcare Professionals: Conventional Antipsychotics”. US Food and Drug Administration. . Arhivat din original la . Accesat în .
medscape.com
- McNamara, Damien (). „Mixed Results for Aducanumab in Two Phase 3 AD Trials”. Medscape.
nice.org.uk
pathways.nice.org.uk
- „Dementia diagnosis and assessment” (PDF). National Institute for Health and Care Excellence (NICE). Arhivat din original (PDF) la . Accesat în .
nice.org.uk
- National Institute for Health and Clinical Excellence. „Low-dose antipsychotics in people with dementia”. National Institute for Health and Care Excellence (NICE). Arhivat din original la . Accesat în .
nih.gov
ncbi.nlm.nih.gov
- Burns A, Iliffe S (februarie 2009). „Alzheimer's disease”. BMJ. 338: b158. doi:10.1136/bmj.b158. ISSN 0959-8138. PMID 19196745.
- Commission de la transparence (iunie 2012). „Drugs for Alzheimer's disease: best avoided. No therapeutic advantage” [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage]. Prescrire International. 21 (128): 150. PMID 22822592.
- Querfurth HW, LaFerla FM (ianuarie 2010). „Alzheimer's disease”. The New England Journal of Medicine. 362 (4): 329–44. doi:10.1056/NEJMra0909142. PMID 20107219.
- Todd S, Barr S, Roberts M, Passmore AP (noiembrie 2013). „Survival in dementia and predictors of mortality: a review”. International Journal of Geriatric Psychiatry. 28 (11): 1109–24. doi:10.1002/gps.3946. PMID 23526458.
- Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (martie 2011). „Alzheimer's disease”. Lancet. 377 (9770): 1019–31. doi:10.1016/S0140-6736(10)61349-9. PMID 21371747.
-
Hsu D, Marshall GA (). „Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward”. Current Alzheimer Research. 14 (4): 426–40. doi:10.2174/1567205013666160930112125. PMC 5329133 . PMID 27697063.
- Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (iulie 2007). „Systematic review of information and support interventions for caregivers of people with dementia”. BMC Geriatrics. 7: 18. doi:10.1186/1471-2318-7-18. PMC 1951962 . PMID 17662119.
- Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (aprilie 2015). „Exercise programs for people with dementia”. The Cochrane Database of Systematic Reviews (Submitted manuscript). 132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMID 25874613.
- GBD 2015 Disease Injury Incidence Prevalence Collaborators (octombrie 2016). „Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 . PMID 27733282.
- Mendez MF (noiembrie 2012). „Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD”. Archives of Medical Research. 43 (8): 677–85. doi:10.1016/j.arcmed.2012.11.009. PMC 3532551 . PMID 23178565.
- GBD 2015 Mortality Causes of Death Collaborators (octombrie 2016). „Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903 . PMID 27733281.
- Berchtold NC, Cotman CW (). „Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s”. Neurobiology of Aging. 19 (3): 173–89. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992.
- Bonin-Guillaume S, Zekry D, Giacobini E, Gold G, Michel JP (ianuarie 2005). „[The economical impact of dementia]”. Presse Médicale (în French). 34 (1): 35–41. doi:10.1016/s0755-4982(05)83882-5. PMID 15685097.
- Meek PD, McKeithan K, Schumock GT (). „Economic considerations in Alzheimer's disease”. Pharmacotherapy. 18 (2 Pt 2): 68–73; discussion 79–82. doi:10.1002/j.1875-9114.1998.tb03880.x (inactiv ). PMID 9543467. Arhivat din original la . Accesat în .
- Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B (ianuarie 2007). „Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline”. European Journal of Neurology. 14 (1): e1–26. doi:10.1111/j.1468-1331.2006.01605.x. PMID 17222085.
- Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (septembrie 2004). „Multiple cognitive deficits during the transition to Alzheimer's disease”. Journal of Internal Medicine. 256 (3): 195–204. doi:10.1111/j.1365-2796.2004.01386.x. PMID 15324363.
- Nygård L (). „Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?”. Acta Neurologica Scandinavica. Supplementum. 179 (s179): 42–6. doi:10.1034/j.1600-0404.107.s179.8.x. PMID 12603250.
- Arnáiz E, Almkvist O (). „Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease”. Acta Neurologica Scandinavica. Supplementum. 179: 34–41. doi:10.1034/j.1600-0404.107.s179.7.x. PMID 12603249.
- Landes AM, Sperry SD, Strauss ME, Geldmacher DS (decembrie 2001). „Apathy in Alzheimer's disease”. Journal of the American Geriatrics Society. 49 (12): 1700–7. doi:10.1046/j.1532-5415.2001.49282.x. PMID 11844006.
- Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. (ianuarie 2004). „Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials”. Archives of Neurology. 61 (1): 59–66. doi:10.1001/archneur.61.1.59. PMID 14732621.
nia.nih.gov
- „About Alzheimer's Disease: Symptoms”. National Institute on Aging. Arhivat din original la . Accesat în .
- „So, What Can You Do?”. National Institute on Aging. . Arhivat din original la .
nytimes.com
scielo.br
- Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (aprilie 2015). „Exercise programs for people with dementia”. The Cochrane Database of Systematic Reviews (Submitted manuscript). 132 (4): CD006489. doi:10.1002/14651858.CD006489.pub4. PMID 25874613.
statnews.com
- Herper, Matthew (). „In shocking reversal, Biogen to submit Alzheimer's drug for approval”. STAT. Accesat în .
In one study, called Emerge, patients on the high-dose aducanumab had a 23% reduction in their rate of decline compared to those on placebo; those who were on the low dose were 11% lower than placebo, but that result was not statistically significant. But in the second trial, Engage, the decrease was only 2% in patients on the high dose.
web.archive.org
- „Dementia diagnosis and assessment” (PDF). National Institute for Health and Care Excellence (NICE). Arhivat din original (PDF) la . Accesat în .
- „About Alzheimer's Disease: Symptoms”. National Institute on Aging. Arhivat din original la . Accesat în .
- „So, What Can You Do?”. National Institute on Aging. . Arhivat din original la .
- National Institute for Health and Clinical Excellence. „Low-dose antipsychotics in people with dementia”. National Institute for Health and Care Excellence (NICE). Arhivat din original la . Accesat în .
- „Information for Healthcare Professionals: Conventional Antipsychotics”. US Food and Drug Administration. . Arhivat din original la . Accesat în .
- Meek PD, McKeithan K, Schumock GT (). „Economic considerations in Alzheimer's disease”. Pharmacotherapy. 18 (2 Pt 2): 68–73; discussion 79–82. doi:10.1002/j.1875-9114.1998.tb03880.x (inactiv ). PMID 9543467. Arhivat din original la . Accesat în .
- 150.000 de români suferă de Alzheimer Arhivat în , la Wayback Machine., 23 septembrie 2009, Otilia Bălinișteanu, Ziarul Lumina, accesat la 2 iulie 2013
who.int
- „Dementia Fact sheet”. World Health Organization. .
wikidata.org
- Monarch Disease Ontology release 2018-06-29[*] Verificați valoarea
|titlelink=(ajutor);
wiley.com
accpjournals.onlinelibrary.wiley.com
- Meek PD, McKeithan K, Schumock GT (). „Economic considerations in Alzheimer's disease”. Pharmacotherapy. 18 (2 Pt 2): 68–73; discussion 79–82. doi:10.1002/j.1875-9114.1998.tb03880.x (inactiv ). PMID 9543467. Arhivat din original la . Accesat în .
worldcat.org
ziarullumina.ro
- 150.000 de români suferă de Alzheimer Arhivat în , la Wayback Machine., 23 septembrie 2009, Otilia Bălinișteanu, Ziarul Lumina, accesat la 2 iulie 2013